Jeff Yass’s Climb Bio CLYM Stock Holding History
Bought
Maintained
Sold
Other funds holding CLYM
Jeff Yass's CLYM Position: Q3 2026 in Review
Jeff Yass increased its Climb Bio (CLYM) stake by 50% in Q3 2026, buying an estimated $213K and bringing the position to 45,550 shares worth $522K. The position accounts for ﹤0.01% of the portfolio, ranked #9648.
Jeff Yass first reported a position in CLYM in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.65M in Q1 2026. 127 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.
- Jeff Yass held 45,550 shares of Climb Bio worth $522K as of Q3 2026.
- Jeff Yass bought 15,271 Climb Bio shares in Q3 2026, an estimated $213K.
- Climb Bio made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #9648 holding.
- Jeff Yass first reported a position in Climb Bio in Q4 2024 and has held it in 8 quarters since.
- Jeff Yass's Climb Bio position peaked at $2.65M in Q1 2026.
- 127 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.